News|Articles|March 28, 2025

Understanding Primary and Secondary Nonadherence to Chronic Oral Medication

Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.

Proactive strategies—such as clear communication, shared decision-making, multidisciplinary collaboration, and standardized documentation—are essential to improving medication adherence in chronic illness. Two studies presented by the American Medical Group Association at this year’s AMGA Annual Conference highlighted the impact of these factors by examining primary and secondary nonadherence to oral anticoagulants (OACs) and anti–prostate cancer medications (OPCM) from the patient and clinician perspectives.